menu
Fragment-Based Drug Discovery Market is estimated to be worth around USD 1.6 billion by 2030
Fragment-Based Drug Discovery Market is estimated to be worth around USD 1.6 billion by 2030
Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery

Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers,2020-2030.”

Thereport features an extensive study of the current market landscape, offering aninformed opinion on the likely adoption of this approach over the next decade.It features an in-depth analysis, highlighting the capabilities of variousstakeholders engaged in this domain. In addition to other elements, the studyincludes:

·       A detailed review of the overall landscape offragment-based drug discovery library and service providers.

·       Elaborate profiles of the companies providinglibraries and services for fragment-based drug discovery (shortlisted on thebasis of the service portfolio and number of fragment screening techniquesoffered).

·       An analysis of the partnerships that havebeen established in the recent past.

·       A detailed analysis on acquisition targets.

·       An insightful competitiveness analysis offragment-based drug discovery library and service providers.

·       An analysis highlighting the cost savingpotential associated with the use of fragment-based drug discovery approach.

Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)

Typeof Technique

·       X-ray Crystallography

·       Nuclear Magnetic Resonance

·       Surface Plasmon Resonance

·       Other Screening Techniques

Typeof Service

·       Library Screening

·       Fragment Screening

·       Fragment Optimization

EndUser

·       Industry Players

·       Non-Industry Players

KeyGeographical Region

·       North America (US and Canada)

·       Europe (UK, France, Germany, Spain, Italy,and rest of Europe)

·       Asia-Pacific (China, Japan, India, and restof Asia-Pacific / rest of the world)

Keycompanies covered in the report

·       2bind

·       Charles River Laboratories

·       ChemAxon

·       ComInnex

·       Creative Biolabs

·       Creative Biostructure

·       CRELUX

·       Domainex

·       Evotec

·       Red Glead Discovery

·       SARomics Biostructures

·       Shanghai ChemPartner

·       Sygnature Discovery

·       Vernalis Research

Requestfor Customization:

https://www.rootsanalysis.com/reports/309/request-customization.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com